At least 42,000 Americans and 70,000 Europeans will be diagnosed with pancreatic cancer in 2020.1 The number could be as high as 57,000 in the US, where the disease is the 9th most commonly diagnosed cancer in women, and the 10th most common in men.2 Moreover, it is the 3rd deadliest form of cancer with a survival rate over 5 years from diagnosis of only 5-8%.1
Early diagnosis in stage I or II is our best chance of fighting this terrible disease, because it is more likely to be treated by surgery before it has had time to spread. Unfortunately, the late onset of symptoms often make it difficult to detect pancreatic cancer in the earlier stages.
If we could detect the disease earlier – when the cancer is still resectable – we could improve survival rates. We could increase the clinicians’ treatment options. And increase patient quality of life and life expectancy. To raise awareness for pancreatic cancer it is crucial to support research, patients and their families.
Read more on immunovia.com